| Drug Name | Zolgensma (onasemnogene abeparvovec) |
|---|---|
| Drug Class |
Gene therapy
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Neurology
|
| Risk |
( teratogenicity ) Fatal Cases of Acute Liver Failure Reported |
| Dear Healthcare provider letter DHPC |
|